Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides

Cancer Research

Volumn 57, Issue 10, 1997, Pages 2013-2019

  Chen, Zhang Qun ^a   Fisher, Robert J ^a   Riggs, Charles W ^b   Rhim, Johng S ^b   Lautenberger, James A ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE FUNCTION; HUMAN; HUMAN CELL; MICROVASCULATURE; PRIORITY JOURNAL; TUMOR GROWTH; UMBILICAL VEIN;

CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GELATIN; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; LAMININ; LYMPHOKINES; MEMBRANES; OLIGONUCLEOTIDES, ANTISENSE; PROTEOGLYCANS; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RNA, MESSENGER; STIMULATION, CHEMICAL; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; URINARY PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030978034     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Folkman, J., and Shing, Y. Angiogenesis, J. Biol. Chem., 267: 10931-10934, 1992.
2. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
3. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., and Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst., 84: 1875-1887, 1992.
4. Nunn, M. F., Seeburg, P. H., Moscovici, C., and Duesberg, P. H. Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature (Lond.), 306: 391-395, 1983.
5. Bhat, N. K., and Papas, T. S. The ETS family of genes: a paradigm for the investigations of oncogenes as transcription factors. In: R. Verna and A. Shamoo (eds.), Challenges in Modern Medicine, Ares-Serono Symposia Publishers, Vol. 5, pp. 63-84. Rome, 1994.
6. Crepieux, P., Coll. J., and Stehelin, D. The Ets family of proteins: weak modulators of gene expression in quest for transcriptional partners. Crit. Rev. Oncog., 5: 615-638, 1994.
7. Bhat, N. K., Fischinger, P. J., Seth, A., Watson, D. K., and Papas, T. Pleiotropic functions of ETS-1. Int. J. Oncol., 8: 841-846, 1996.
8. Chen, J. H. The proto-oncogene c-ets is preferentially expressed in lymphoid cells. Mol. Cell. Biol., 5: 2993-3000, 1985.
9. Bhat, N. K., Fisher, R. J., Fujiwara, S., Ascione, R., and Papas, T. S. Temporal and tissue-specific expression of mouse ets genes. Proc. Natl. Acad. Sci. USA, 84: 3161-3165, 1987.
10. Bhat, N. K., Komschlies, K. L., Fujiwara, S., Fisher, R. J., Mathieson, B. J., Gregorio, T. A., Young, H. A., Kasik, J. W., Ozato, K., and Papas, T. S. Expression of ets genes in mouse thymocyte subsets and T cells. J. Immunol., 142: 672-678, 1989.
11. Vandenbunder, B., Pardanaud, L., Jaffredo, T., Mirabel, M. A., and Stehelin, D. Complementary patterns of expression of c-ets1, c-myb and c-myc in the blood-forming system of the chick embryo. Development (Camb.), 107: 265-274, 1989.
12. Maroulakou, I. G., Papas, T. S., and Green, J. E. Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene, 9: 1551-1565, 1994.
13. Wernert, N., Raes, M. B., Lassalle, P., Dehouck, M. P., Gosselin, B., Vandenbunder, B., and Stehelin, D. c-etsl proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol., 140: 119-127, 1992.
14. Wernert, N., Gilles, F., Fafeur, V., Bouali, F., Raes, M. B., Pyke, C., Dupressoir, T., Seitz, G., Vandenbunder, B., and Stehelin, D. Stromal expression of c-Ets 1 transcription factor correlates with tumor invasion. Cancer Res., 54: 5683-5688, 1994.
15. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.), 367: 576-579, 1994.
16. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362: 841-844, 1993.
17. Fisher, R. J., Koizumi, S., Kondoh, A., Mariano, J. M., Mavrothalassitis, G., Bhat, N. K., and Papas, T. S. Human ETS1 oncoprotein. Purification, isoforms, -SH modification, and DNA sequence-specific binding. J. Biol. Chem., 267: 17957-17965, 1992.
18. Chen, Z. Q., Kan, N. C., Pribyl, L., Lautenberger, J. A., Moudrianakis, E., and Papas, T. S. Molecular cloning of the ets proto-oncogene of the sea urchin and analysis of its developmental expression. Dev. Biol., 125: 432-440, 1988.
19. Watson, D. K., McWilliams, M. J., Lapis, P., Lautenberger, J. A., Schweinfest, C., and Papas, T. S. Mammalian ets-1 and ets-2 genes encode highly conserved proteins. Proc. Natl. Acad. Sci. USA, 85: 7862-7866, 1988.
20. Watson, D. K., Smyth, F. E., Thompson, D. M., Cheng, J. Q., Testa, J. R., Papas, T. S., and Seth, A. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Cell Growth & Differ., 3: 705-713, 1992.
21. Harlow, E., and Lane, D. Antibodies: A Laboratory Manual, p. 449. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988.
22. Bhat, N. K., and Papas, T. S. Characterization and uses of monoclonal antibody derived against DNA binding domain of the ets family of genes. Hybridoma, 11: 277-294, 1992.
23. Koizumi, S., Fisher, R. J., Fujiwara, S., Jorcyk, C., Bhat, N. K., Seth, A., and Papas, T. S. Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation. Oncogene, 5: 675-681, 1990.
24. Bennett, C. F., Chiang, M. Y., Chan, H., Shoemaker, J. E., and Mirabelli, C. K. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol., 41: 1023-1033, 1992.
25. Taraboletti, G., Roberts, D., Liotta, L. A., and Giavzzi, R. Platelet thrombospondin modulates endothelial cell adhesion, motility and growth: a potential angiogenesis regulatory factor. J. Cell. Biol., 111: 765-772, 1990.
26. Blasi, F. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays, 15: 105-111, 1993.
27. Breier, G., Albrecht, U., Sterrer, S., and Risau, W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development (Camb.), 114: 521-532, 1992.
28. Peters, K. G., De Vries, C., and Williams, L. T. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl. Acad. Sci. USA, 90: 8915-8919, 1993.
29. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., and Schuh, A. C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature (Lond.), 376: 62-66, 1995.
30. Werner, M. H., Clore, G. M., Fisher, C. L., Fisher, R. J., Trinh, L., Shiloach, J., and Gronenborn, A. M. The solution structure of the human ETS1-DNA complex reveals a novel mode of binding and true side chain intercalation. Cell, 83: 761-771, 1995. [published erratum appears in Cell, 87: following 355, 1996]
31. Rorth, P., Nerlov, C., Blasi, F., and Johnsen, M. Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester. Nucleic Acids. Res., 18: 5009-5017, 1990.
32. Wagner, R. W. Gene inhibition using antisense oligonucleotides. Nature (Lond.), 372: 333-335, 1994.
33. 2 and tumor necrosis factor-α activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J. Biol. Chem., 270: 18966-18974, 1995.
34. Bories, J-C., Willerford, D. M., Grevin, D., Davidson, L., Camus, A., Martin, P., Stehelin, D., and Alt, F. W. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature (Lond.), 377: 635-638, 1995.
35. Muthusamy, N., Barton, K., and Leiden, J. M. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature (Lond.), 377: 639-642, 1995.
36. Baillie, C. T., Winslet, M. C., and Bradley, N. J. Tumour vasculature: a potential therapeutic target. Br. J. Cancer, 72: 257-267, 1995.